“What if your cancer was discovered by a genetic test?” it asked.
“Do you really want to spend $20,000 or $30,000 on a new lab test?
We know that there is a huge number of cancer patients who are looking for the best cancer screening test, the most cost-effective test, and this is the kind of thing that could be done for a small amount of money, for a few dollars.”
The answer is “no,” says Dr. Richard Murnane, an oncologist and chairman of the Oncology Committee at Brigham and Women’s Hospital, where he leads the OncoLab program.
“You want to know if you have a reasonable chance of being cured, and if you can do it in a safe way,” Murnaneson says.
“So that’s what we’re trying to do.
This is the sort of thing you can use in the laboratory.
This isn’t the sort a person would have to go to their doctor to do, or that they would go to the hospital for.
It’s not something that would be expensive, it’s not invasive, and it’s safe.”
Dr. Stephen B. Dabakis, a specialist in oncologic oncological oncologists and president of the Society of Oncologists, agrees that “this is a very safe and inexpensive way to treat cancer.”
And it may also offer a glimpse into the future of oncogenomics, a field that is being rapidly transformed by genetic testing.
Dabakis believes oncogenic genetic tests are being used to determine if cancer patients should receive chemotherapies, or chemotherapy, and that the technology will ultimately be used to improve the health of people with cancer who do not respond to conventional treatments.
Oncogenomic tests can also be used for detecting tumors and detecting early signs of cancer, he says.
He also sees the testing of DNA samples as an exciting way to learn about genetic diseases and to determine what the true risk of cancer is.
“We have to do more to get people to do these tests.
I think this is really exciting and very innovative and we can do things in the lab that will really accelerate that,” he says, adding that he believes it could be an “apprentice technology.”